Keenova Therapeutics plc Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Keenova Therapeutics plc reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $5.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-04-15
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2021-12-31 was $0.00.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2021-09-24 was $14.50M, a 59.38% decline year-over-year.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2020-09-25 was $35.70M, a 264.29% increase year-over-year.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2020-06-26 was $20.50M.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $5.00M.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $0.00.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2021 was $21.80M, a 39.44% decline from fiscal 2020.
- Keenova Therapeutics plc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2020 was $36.00M, a 43.43% increase from fiscal 2019.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 1 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 5 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 6 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 9 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 10 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $5.00M 10-K · filed 2026-04-15 | ||||||
| 2024-12-27 | $0.00 10-K · filed 2026-04-15 | ||||||
| 2023-12-29 | $0.00 10-K · filed 2025-03-13 | ||||||
| 2023-11-14 | $0.00 10-K · filed 2025-03-13 | ||||||
| 2022-12-30 | $0.00 10-K · filed 2025-03-13 | ||||||
| 2022-06-16 | $0.00 10-K · filed 2025-03-13 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $14.50M derived: sum of 2 quarters · filed 2024-03-26 | $21.80M 10-K · filed 2024-03-26 | ||||
| 2021-09-24 | $14.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $21.80M 10-Q · filed 2021-11-02 | |||||
| 2021-06-25 | $7.30M 10-Q · filed 2021-08-03 | ||||||
| 2020-12-25 | $36.00M 10-K · filed 2023-03-03 | ||||||
| 2020-09-25 | $35.70M 10-Q · filed 2020-11-03 | $56.20M derived: sum of 2 quarters · filed 2020-11-03 | $61.00M derived: sum of 3 quarters · filed 2020-11-03 | $73.00M derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-06-26 | $20.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $25.30M 10-Q · filed 2020-08-04 | $37.30M derived: sum of 3 quarters · filed 2022-03-15 | $47.10M derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-03-27 | $4.80M 10-Q · filed 2020-05-06 | $16.80M derived: sum of 2 quarters · filed 2022-03-15 | $26.60M derived: sum of 3 quarters · filed 2022-03-15 | ||||
| 2019-12-27 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $21.80M derived: sum of 2 quarters · filed 2022-03-15 | $25.10M 10-K · filed 2022-03-15 | ||||
| 2019-09-27 | $9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $13.10M 10-Q · filed 2019-11-05 | |||||
| 2019-06-28 | $3.30M 10-Q · filed 2019-08-06 | ||||||
| 2018-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $4.80M 10-K · filed 2021-03-10 | |||||
| 2018-09-28 | $4.80M 10-Q · filed 2018-11-06 | ||||||
| 2017-12-29 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.10M derived: sum of 2 quarters · filed 2020-02-26 | $2.80M 10-K · filed 2020-02-26 | ||||
| 2017-09-29 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.70M 10-Q · filed 2017-11-07 | |||||
| 2017-06-30 | $1.70M 10-Q · filed 2017-08-08 | ||||||
| 2016-12-30 | $0.00 10-K · filed 2019-02-26 | $200.00K derived: sum of 2 quarters · filed 2019-02-26 | $1.10M derived: sum of 3 quarters · filed 2019-02-26 | ||||
| 2016-09-30 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.10M derived: sum of 2 quarters · filed 2019-02-26 | $2.00M 10-K · filed 2019-02-26 | ||||
| 2016-06-24 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-02 | $1.80M 10-Q · filed 2016-08-02 | |||||
| 2016-03-25 | $900.00K 10-Q · filed 2016-05-03 | ||||||
| 2015-09-25 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $400.00K derived: sum of 2 quarters · filed 2018-02-27 | $900.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.70M 10-K · filed 2018-02-27 | |||
| 2015-06-26 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $700.00K derived: sum of 2 quarters · filed 2015-08-04 | $1.50M 10-Q · filed 2015-08-04 | $3.70M derived: sum of 4 quarters · filed 2016-11-29 | |||
| 2015-03-27 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-05 | $1.30M 10-Q · filed 2015-05-05 | $3.50M derived: sum of 3 quarters · filed 2016-11-29 | $5.50M derived: sum of 4 quarters · filed 2016-11-29 | |||
| 2014-12-26 | $800.00K 10-Q · filed 2015-02-03 | $3.00M derived: sum of 2 quarters · filed 2016-11-29 | $5.00M derived: sum of 3 quarters · filed 2016-11-29 | $8.60M derived: sum of 4 quarters · filed 2016-11-29 | |||
| 2014-09-26 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $4.20M derived: sum of 2 quarters · filed 2016-11-29 | $7.80M derived: sum of 3 quarters · filed 2016-11-29 | $12.00M 10-K · filed 2016-11-29 | |||
| 2014-06-27 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-07 | $5.60M derived: sum of 2 quarters · filed 2014-08-07 | $9.80M 10-Q · filed 2014-08-07 | ||||
| 2014-03-28 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-08 | $7.80M 10-Q · filed 2014-05-08 | |||||
| 2013-12-27 | $4.20M 10-Q · filed 2014-02-07 | ||||||
| 2013-09-27 | $100.00K 10-K · filed 2015-11-24 | ||||||
| 2012-09-28 | $2.20M 8-K · filed 2015-04-03 | ||||||
| 2011-09-30 | $0.00 10-K · filed 2013-12-13 |